Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
208 Leser
Artikel bewerten:
(0)

Sectra's Digital Pathology Solution Selected for External Quality Assurance Program

LINKÖPING, Sweden, Oct. 18, 2017 /PRNewswire/ --

International medical imaging IT and cybersecurity companySectra(STO: SECT B) signs digital pathology contract with the Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP). Sectra's digital pathology solution will be used in training and quality assurance programs for pathology laboratories. It will provide pathologists and scientists with a fast digital pathology solution, available at any time regardless of the participant's location.

"The Sectra solution will enable us to deliver digital slides and a consistent user experience in difficult image programs, such as cytopathology. This due to its ability to provide a seamless microscope-like experience even on heavily z-stacked virtual slides, mobile devices and lower bandwidth connections," says Derek Holzhauser, Chief Information Officer at RCPAQAP.

The solution will be used for the external quality assurance (EQA) programs that RCPA offers in Australia and in more than 60 other countries. Pathologists and scientists will have access to Sectra's solution through the program portal where they will receive cases and associated questions for assessment. The solution's zero-footprint viewer and smart streaming functionality enable access to the digital pathology images without large installations, at any time and in remote areas.

Sectra's digital pathology solution

Sectra provides a complete solution for primary diagnostics in pathology. Sectra's high-end review workstation provides pathologists with the right environment and tools to perform their work in a digital system and to reduce the pain-points associated with time-consuming and labor-intensive manual workflow. Sectra's digital pathology solution also allows seamless sharing of digital slides and patient data in multi-hospital environments, enhancing the workflows around consultations, frozen sections and second opinions.

The solution is part of Sectra's enterprise imaging solution that also supports radiology, cardiology, mammography, orthopaedics and other medical imaging. Since it is built on the same technical platform, Sectra's solution enables efficient integrated diagnostic workflows, supporting improved collaboration between radiology and pathology, two key players in efficient cancer care.

For further information, please contact::

Dr. Torbjörn Kronander,
CEO and President
Sectra AB, 46(0)705-23-52-27

Marie Ekström Trägårdh,
Executive Vice President Sectra AB and President Sectra Imaging IT Solutions,
46(0)708-23-56-10

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/sectra/r/sectra-s-digital-pathology-solution-selected-for-external-quality-assurance-program,c2368875

The following files are available for download:

http://news.cision.com/sectra/i/sectra-digital-pathology,c2250883

Sectra digital pathology

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.